Becca Stanek is an experienced writer and editor who is passionate about exploring the ways we can feel better mentally and physically to get the most out of our lives. She has worked for publications ...
The maker of the ADHD drug Vyvanse has been given approval by the US Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues. HealthDay News — The ...
To address the nationwide shortage of medications for attention-deficit/hyperactivity disorder, the Drug Enforcement Administration is allowing an increase in the ...
In a significant move to mitigate the ongoing shortage of ADHD medications in the U.S., the Drug Enforcement Administration (DEA) has authorized a substantial increase in the production limits for ...
To address an ongoing shortage of ADHD drugs, the Drug Enforcement Administration has increased the production quota on Takeda's Vyvanse and its generic versions by 24%. (Photo by KAZUHIRO NOGI/AFP ...
Takeda says the situation affects its 40-mg, 60-mg and 70-mg dosage strengths of Vyvanse. The 40-mg dose supply "will dip in mid-June and will be replenished in a few weeks," according to Takeda's ...
LONDON (Reuters) - Shire has struck a deal with GlaxoSmithKline, the world's second largest drugs group, to co-promote its hyperactivity medicine Vyvanse in the United States, sending its shares ...
WASHINGTON — The Drug Enforcement Administration has increased the production limit for the ADHD drug Vyvanse and its generic versions to combat the medicine's ongoing shortage, according to a notice ...
Verywell Health on MSN
Concerta vs. Vyvanse: How do they compare for ADHD?
Concerta and Vyvanse are both long-acting stimulant medications taken to treat ADHD, but they differ in their formulations and additional uses. Both medications effectively improve focus, attention, ...
Takeda Pharmaceutical Co Ltd (NYSE: TAK), a manufacturer of Vyvanse, has confirmed that the drug is experiencing low inventory due to manufacturing complications. A spokesperson from the company ...
The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues. Following a request ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results